What is Stereotaxis?
Stereotaxis (NYSE: STXS) is at the forefront of developing and delivering robotic systems, instruments, and information solutions designed for the interventional laboratory. Its core mission revolves around enhancing patient care through robotic precision, expanding access to minimally invasive therapies, and improving the productivity and intelligence within surgical environments. The company's innovations are crucial for physicians seeking to provide unsurpassed patient care while navigating complex endovascular procedures.
How much funding has Stereotaxis raised?
Stereotaxis has raised a total of $497.1M across 23 funding rounds:
Stock Offering
$10.2M
Debt
$10M
Share Placement
$24M
Other Financing Round
$10M
Share Placement
$25M
Debt
$2M
Share Placement
$15M
Other Financing Round
$50M
Stock Issuance/Offering (2013): $10.2M with participation from Undisclosed
Debt (2014): $10M led by Silicon Valley Bank
Share Placement (2016): $24M supported by Joe Kiani and DAFNA Capital Management
Other Financing Round (2018): $10M featuring Undisclosed
Share Placement (2019): $25M backed by Redmile Group, Parkman Healthcare Partners, and Opaleye Management
Debt (2020): $2M with participation from PPP
Share Placement (2020): $15M led by Consonance Capital Management
Other Financing Round (2025): $50M supported by Roth Capital Partners
Key Investors in Stereotaxis
Advent International
Advent International is a leading global private equity firm specializing in buyouts and growth equity, with a strong focus on the healthcare sector. They leverage deep sub-sector expertise and a global network to drive long-term value creation.
Ascension Ventures
Ascension Ventures is a strategic healthcare venture firm that invests on behalf of leading community health systems, focusing on companies transforming the healthcare industry.
CID Equity Partners
CID Capital is a private equity group that makes control investments in lower middle market companies with a track record of success, providing capital for expansion and growth.
What's next for Stereotaxis?
With substantial enterprise-level backing and a recent strategic investment, Stereotaxis is poised for continued innovation and market expansion. The company's focus on advancing surgical robotics suggests a trajectory aimed at further integrating AI and data-driven insights into interventional procedures. Future developments are likely to center on enhancing the capabilities of its robotic platforms, broadening their application across various medical specialties, and solidifying its position as a key player in the rapidly evolving field of medical technology and robotic surgery.
See full Stereotaxis company page
